|
|
||||||||

* Department of Pharmacology, College of Medicine and Department of Molecular Pharmacology, Neuroscience Research Institute, MRC Seoul National University, Biomedical Brain Research Center, NIH, Seoul 110799, South Korea;
Department of Pharmacology and Toxicology, Kyorin University, School of Medicine, Mitaka, Tokyo 181, Japan; and
§ Department of Chemistry, College of Natural Science, Konkuk University, Seoul, Korea
1Correspondence: Department of Pharmacology, College of Medicine, Seoul National University, Yongon-dong, 28, Chongno-ku, Seoul 110799, Korea. E-mail:yhsuh{at}plaza.snu.ac.kr
Numerous lines of evidence indicate that some of the neurotoxicity associated with Alzheimers disease (AD) is due to proteolytic fragments of the amyloid precursor protein (APP). Most research has focused on the amyloid ß peptide (Aß). However, the possible role of other cleaved products of APP is less clear. We have previously shown that a recombinant carboxy-terminal 105 amino acid fragment (CT 105) of APP induced strong nonselective inward currents in Xenopus oocyte; it also revealed neurotoxicity in PC12 cells and primary cortical neurons, blocked later phase of long-term potentiation in rat hippocampus in vivo, and induced memory deficits and neuropathological changes in mice. We report here that the pretreatment with CT 105 for 24 h at a 10 µM concentration increases intracellular calcium concentration by about twofold in SK-N-SH and PC 12 cells, but not in U251 cells, originated from human glioblastoma. In addition, the calcium increase and toxicity induced by CT 105 were reduced by cholesterol and MK 801 in SK-N-SH and PC 12 cells, whereas the toxicity of Aß142 was attenuated by nifedipine and verapamil. CT 105 rendered SK-N-SH cells and rat primary cortical neurons more vulnerable to glutamate-induced excitotoxicity. Also, conformational studies using circular dichroism experiments showed that CT 105 has ~15% of ß-sheet content in phosphate buffer and aqueous 2,2,2-trifluoroethanol solutions. However, the content of ß-sheet conformation in dodecyl phosphocholine micelle or in the negatively charged vesicles, is increased to 22%23%. The results of this study showed that CT 105 disrupts calcium homeostasis and renders neuronal cells more vulnerable to glutamate-induced excitotoxicity, and that some portion of CT 105 has partial ß-sheet conformation in various environments, which may be related to the self-aggregation and toxicity. This may be significantly possibly involved in inducing the neurotoxicity characteristic of AD.Kim, H.-S., Park, C. H., Cha, S. H., Lee, J.-H., Lee, S., Kim, Y., Rah, J.-C., Jeong, S.-J., Suh, Y.-H. Carboxyl-terminal fragment of Alzheimers APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity.
Key Words: amyloid precursor protein Intracellular free calcium concentration Alzheimers disease glutamate ß-sheet conformation
This article has been cited by other articles:
![]() |
C. Supnet, J. Grant, H. Kong, D. Westaway, and M. Mayne Amyloid-beta-(1-42) Increases Ryanodine Receptor-3 Expression and Function in Neurons of TgCRND8 Mice J. Biol. Chem., December 15, 2006; 281(50): 38440 - 38447. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Malm, M. Ort, L. Tahtivaara, N. Jukarainen, G. Goldsteins, J. Puolivali, A. Nurmi, R. Pussinen, T. Ahtoniemi, T.-K. Miettinen, et al. beta-Amyloid infusion results in delayed and age-dependent learning deficits without role of inflammation or beta-amyloid deposits PNAS, June 6, 2006; 103(23): 8852 - 8857. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rockenstein, M. Mante, M. Alford, A. Adame, L. Crews, M. Hashimoto, L. Esposito, L. Mucke, and E. Masliah High {beta}-Secretase Activity Elicits Neurodegeneration in Transgenic Mice Despite Reductions in Amyloid-{beta} Levels: IMPLICATIONS FOR THE TREATMENT OF ALZHEIMER DISEASE J. Biol. Chem., September 23, 2005; 280(38): 32957 - 32967. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Chong, Y. J. Shin, and Y.-H. Suh Cyclic AMP Inhibition of Tumor Necrosis Factor alpha Production Induced by Amyloidogenic C-Terminal Peptide of Alzheimer's Amyloid Precursor Protein in Macrophages: Involvement of Multiple Intracellular Pathways and Cyclic AMP Response Element Binding Protein Mol. Pharmacol., March 1, 2003; 63(3): 690 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Herms, I. Schneider, I. Dewachter, N. Caluwaerts, H. Kretzschmar, and F. Van Leuven Capacitive Calcium Entry Is Directly Attenuated by Mutant Presenilin-1, Independent of the Expression of the Amyloid Precursor Protein J. Biol. Chem., January 17, 2003; 278(4): 2484 - 2489. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Suh and F. Checler Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease Pharmacol. Rev., September 1, 2002; 54(3): 469 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Fitzjohn, R. A. Morton, F. Kuenzi, T. W. Rosahl, M. Shearman, H. Lewis, D. Smith, D. S. Reynolds, C. H. Davies, G. L. Collingridge, et al. Age-Related Impairment of Synaptic Transmission But Normal Long-Term Potentiation in Transgenic Mice that Overexpress the Human APP695SWE Mutant Form of Amyloid Precursor Protein J. Neurosci., July 1, 2001; 21(13): 4691 - 4698. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Yu and P. E. Fraser S100{beta} Interaction with Tau Is Promoted by Zinc and Inhibited by Hyperphosphorylation in Alzheimer's Disease J. Neurosci., April 1, 2001; 21(7): 2240 - 2246. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Kim, R. Anwyl, Y.-H. Suh, M. B. A. Djamgoz, and M. J. Rowan Use-Dependent Effects of Amyloidogenic Fragments of {beta}-Amyloid Precursor Protein on Synaptic Plasticity in Rat Hippocampus In Vivo J. Neurosci., February 15, 2001; 21(4): 1327 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Chong, J. H. Sung, S. A. Shin, J.-H. Chung, and Y.-H. Suh Effects of the beta -Amyloid and Carboxyl-terminal Fragment of Alzheimer's Amyloid Precursor Protein on the Production of the Tumor Necrosis Factor-alpha and Matrix Metalloproteinase-9 by Human Monocytic THP-1 J. Biol. Chem., June 22, 2001; 276(26): 23511 - 23517. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |